Fig. 8: Molecular docking interactions between BBB permeant candidate drugs and target proteins. | npj Parkinson's Disease

Fig. 8: Molecular docking interactions between BBB permeant candidate drugs and target proteins.

From: Peripheral immune cell-specific genes in Parkinson’s disease uncovered by multi-omics with therapeutic implications

Fig. 8: Molecular docking interactions between BBB permeant candidate drugs and target proteins.The alternative text for this image may have been generated using AI.

A Amodiaquine and CTSB. B Methadone hydrochloride and ARSA. C Alprazolam and CTSB. D Felodipine and CTSB. Left: protein-ligand complex; center: close-up of binding site; right: 2D interaction map highlighting key residues and binding types.

Back to article page